Exact Mass: 443.2209

Exact Mass Matches: 443.2209

Found 24 metabolites which its exact mass value is equals to given mass value 443.2209, within given mass tolerance error 0.001 dalton. Try search metabolite list with more accurate mass tolerance error 0.0002 dalton.

   

Cys Lys Pro Pro

(2S)-1-{[(2S)-1-[(2S)-6-amino-2-[(2R)-2-amino-3-sulfanylpropanamido]hexanoyl]pyrrolidin-2-yl]carbonyl}pyrrolidine-2-carboxylic acid

C19H33N5O5S (443.2202)


   

Cys Pro Lys Pro

(2S)-1-[(2S)-6-amino-2-{[(2S)-1-[(2R)-2-amino-3-sulfanylpropanoyl]pyrrolidin-2-yl]formamido}hexanoyl]pyrrolidine-2-carboxylic acid

C19H33N5O5S (443.2202)


   

Cys Pro Pro Lys

(2S)-6-amino-2-{[(2S)-1-{[(2S)-1-[(2R)-2-amino-3-sulfanylpropanoyl]pyrrolidin-2-yl]carbonyl}pyrrolidin-2-yl]formamido}hexanoic acid

C19H33N5O5S (443.2202)


   

Lys Cys Pro Pro

(2S)-1-{[(2S)-1-[(2R)-2-[(2S)-2,6-diaminohexanamido]-3-sulfanylpropanoyl]pyrrolidin-2-yl]carbonyl}pyrrolidine-2-carboxylic acid

C19H33N5O5S (443.2202)


   

Lys Pro Cys Pro

(2S)-1-[(2R)-2-{[(2S)-1-[(2S)-2,6-diaminohexanoyl]pyrrolidin-2-yl]formamido}-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid

C19H33N5O5S (443.2202)


   

Lys Pro Pro Cys

(2R)-2-{[(2S)-1-{[(2S)-1-[(2S)-2,6-diaminohexanoyl]pyrrolidin-2-yl]carbonyl}pyrrolidin-2-yl]formamido}-3-sulfanylpropanoic acid

C19H33N5O5S (443.2202)


   

Pro Cys Lys Pro

(2S)-1-[(2S)-6-amino-2-[(2R)-2-[(2S)-pyrrolidin-2-ylformamido]-3-sulfanylpropanamido]hexanoyl]pyrrolidine-2-carboxylic acid

C19H33N5O5S (443.2202)


   

Pro Cys Pro Lys

(2S)-6-amino-2-{[(2S)-1-[(2R)-2-[(2S)-pyrrolidin-2-ylformamido]-3-sulfanylpropanoyl]pyrrolidin-2-yl]formamido}hexanoic acid

C19H33N5O5S (443.2202)


   

Pro Lys Cys Pro

(2S)-1-[(2R)-2-[(2S)-6-amino-2-[(2S)-pyrrolidin-2-ylformamido]hexanamido]-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid

C19H33N5O5S (443.2202)


   

Pro Lys Pro Cys

(2R)-2-{[(2S)-1-[(2S)-6-amino-2-[(2S)-pyrrolidin-2-ylformamido]hexanoyl]pyrrolidin-2-yl]formamido}-3-sulfanylpropanoic acid

C19H33N5O5S (443.2202)


   

Pro Pro Cys Lys

(2S)-6-amino-2-[(2R)-2-{[(2S)-1-{[(2S)-pyrrolidin-2-yl]carbonyl}pyrrolidin-2-yl]formamido}-3-sulfanylpropanamido]hexanoic acid

C19H33N5O5S (443.2202)


   

Pro Pro Lys Cys

(2R)-2-[(2S)-6-amino-2-{[(2S)-1-{[(2S)-pyrrolidin-2-yl]carbonyl}pyrrolidin-2-yl]formamido}hexanamido]-3-sulfanylpropanoic acid

C19H33N5O5S (443.2202)


   

2-[8-(2-Naphthalenylmethyl)-4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-3-yl]acetic acid methyl ester

2-[8-(2-Naphthalenylmethyl)-4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-3-yl]acetic acid methyl ester

C27H29N3O3 (443.2209)


   

2-[4-Methoxy-3-(4-morpholinylmethyl)phenyl]-3-(phenylmethyl)-1,2-dihydroquinazolin-4-one

2-[4-Methoxy-3-(4-morpholinylmethyl)phenyl]-3-(phenylmethyl)-1,2-dihydroquinazolin-4-one

C27H29N3O3 (443.2209)


   

1-[(3aS,4R,9bR)-4-(hydroxymethyl)-8-(3-methoxyphenyl)-5-methyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinolin-1-yl]-2-pyridin-4-ylethanone

1-[(3aS,4R,9bR)-4-(hydroxymethyl)-8-(3-methoxyphenyl)-5-methyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinolin-1-yl]-2-pyridin-4-ylethanone

C27H29N3O3 (443.2209)


   

(6S,7R,8R)-7-[4-(3-cyclopentylprop-1-ynyl)phenyl]-8-(hydroxymethyl)-4-[oxo(3-pyridinyl)methyl]-1,4-diazabicyclo[4.2.0]octan-2-one

(6S,7R,8R)-7-[4-(3-cyclopentylprop-1-ynyl)phenyl]-8-(hydroxymethyl)-4-[oxo(3-pyridinyl)methyl]-1,4-diazabicyclo[4.2.0]octan-2-one

C27H29N3O3 (443.2209)


   

4-[4-[(6R,7R,8S)-4-[cyclohexyl(oxo)methyl]-8-(hydroxymethyl)-2-oxo-1,4-diazabicyclo[4.2.0]octan-7-yl]phenyl]benzonitrile

4-[4-[(6R,7R,8S)-4-[cyclohexyl(oxo)methyl]-8-(hydroxymethyl)-2-oxo-1,4-diazabicyclo[4.2.0]octan-7-yl]phenyl]benzonitrile

C27H29N3O3 (443.2209)


   

4-[4-[(6R,7R,8R)-4-[cyclohexyl(oxo)methyl]-8-(hydroxymethyl)-2-oxo-1,4-diazabicyclo[4.2.0]octan-7-yl]phenyl]benzonitrile

4-[4-[(6R,7R,8R)-4-[cyclohexyl(oxo)methyl]-8-(hydroxymethyl)-2-oxo-1,4-diazabicyclo[4.2.0]octan-7-yl]phenyl]benzonitrile

C27H29N3O3 (443.2209)


   

NNC 63-0532

NNC 63-0532

C27H29N3O3 (443.2209)


NNC63-0532 is a novel non-peptide nociceptin receptor (ORL1) agonist, with EC50s of 305?nM. NNC63-0532 plays important roles in many disorders such as pain, drug addiction[1].

   

(1r,4s,7s,9r)-16-acetyl-4-benzyl-6-hydroxy-9-(2-methylbut-3-en-2-yl)-2,5,16-triazatetracyclo[7.7.0.0²,⁷.0¹⁰,¹⁵]hexadeca-5,10,12,14-tetraen-3-one

(1r,4s,7s,9r)-16-acetyl-4-benzyl-6-hydroxy-9-(2-methylbut-3-en-2-yl)-2,5,16-triazatetracyclo[7.7.0.0²,⁷.0¹⁰,¹⁵]hexadeca-5,10,12,14-tetraen-3-one

C27H29N3O3 (443.2209)


   

(1r,4s,9r)-16-acetyl-4-benzyl-6-hydroxy-9-(2-methylbut-3-en-2-yl)-2,5,16-triazatetracyclo[7.7.0.0²,⁷.0¹⁰,¹⁵]hexadeca-5,10,12,14-tetraen-3-one

(1r,4s,9r)-16-acetyl-4-benzyl-6-hydroxy-9-(2-methylbut-3-en-2-yl)-2,5,16-triazatetracyclo[7.7.0.0²,⁷.0¹⁰,¹⁵]hexadeca-5,10,12,14-tetraen-3-one

C27H29N3O3 (443.2209)


   

3,14,14,21,21-pentamethyl-20-oxa-5,11,16-triazahexacyclo[13.11.0.0³,¹¹.0⁵,⁹.0¹⁷,²⁶.0¹⁹,²⁴]hexacosa-1(15),8,12,17,19(24),22,25-heptaene-4,10-dione

3,14,14,21,21-pentamethyl-20-oxa-5,11,16-triazahexacyclo[13.11.0.0³,¹¹.0⁵,⁹.0¹⁷,²⁶.0¹⁹,²⁴]hexacosa-1(15),8,12,17,19(24),22,25-heptaene-4,10-dione

C27H29N3O3 (443.2209)


   

16-acetyl-4-benzyl-6-hydroxy-9-(2-methylbut-3-en-2-yl)-2,5,16-triazatetracyclo[7.7.0.0²,⁷.0¹⁰,¹⁵]hexadeca-5,10,12,14-tetraen-3-one

16-acetyl-4-benzyl-6-hydroxy-9-(2-methylbut-3-en-2-yl)-2,5,16-triazatetracyclo[7.7.0.0²,⁷.0¹⁰,¹⁵]hexadeca-5,10,12,14-tetraen-3-one

C27H29N3O3 (443.2209)